Surgical Treatment for the Displaced JakobⅡ Classification Humerus Lateral Condylar Fractures in Children
JCHLCF
Multi-center Study on Surgical Treatment for the Displaced JakobⅡ Classification Humerus Lateral Condylar Fractures in Children
1 other identifier
observational
100
1 country
1
Brief Summary
Multi-center Study on Surgical Treatment for the Displaced JakobⅡ Classification Humerus Lateral Condylar Fractures in Children.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2018
CompletedFirst Submitted
Initial submission to the registry
January 31, 2018
CompletedFirst Posted
Study publicly available on registry
February 27, 2018
CompletedMarch 19, 2018
February 1, 2018
Same day
January 31, 2018
March 15, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Radiographic union
Radiographic union in surgical treatment for the Displaced JakobⅡ Classification Humerus Lateral Condylar Fractures in Children.
Up to 12 weeks.
Secondary Outcomes (1)
Fracture displacement
Up to 12 weeks.
Other Outcomes (1)
Functional clinical scores
Through study completion, an average of 1 year.
Study Arms (2)
Closed reduction
The children were treated with closed reduction.
Open reduction
The children were treated with open reduction.
Interventions
Eligibility Criteria
Surgical Treatment for the Displaced JakobⅡ Classification Humerus Lateral Condylar Fractures in Children.
You may qualify if:
- Patients with fractures that met these criteria, underwent definitive surgery and had complete clinical and radiographic follow up until fracture union at either institution were included in this study.
You may not qualify if:
- Pathologic fractures, and fractures in patients with osteogenesis imperfecta, neuromuscular disorders or any systemic disease that was associated with a predisposition to fractures or altered fracture healing were excluded.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Shunyou Chenlead
Study Sites (1)
Shunyou Chen
Fuzhou, Fujian, 350007, China
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Chen Shunyou, Phd
The Fuzhou No 2 Hospital
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Director,Head of Orthopaedics
Study Record Dates
First Submitted
January 31, 2018
First Posted
February 27, 2018
Study Start
January 1, 2018
Primary Completion
January 1, 2018
Study Completion
January 1, 2018
Last Updated
March 19, 2018
Record last verified: 2018-02